枫树
发表于 2025-3-26 22:09:59
http://reply.papertrans.cn/19/1813/181273/181273_31.png
CRATE
发表于 2025-3-27 01:36:34
http://reply.papertrans.cn/19/1813/181273/181273_32.png
争吵
发表于 2025-3-27 06:56:45
http://reply.papertrans.cn/19/1813/181273/181273_33.png
tackle
发表于 2025-3-27 12:18:47
Image Reconstruction, acquired data stored in sinograms. The FBP using various filters is accomplished by the Fourier technique. Two iterative methods—MLEM and OSEM—are applied, of which the OSEM is most widely used because of the shorter time required in image reconstruction. An example of the OSEM method is illustrate
SUGAR
发表于 2025-3-27 16:00:34
Storage, Display, and PACS,orm a flowchart called workflow which is offered by vendors in the form of a software. Computers are used to perform each of these activities. Local and off-site storages are used to store patient information in DICOM format from both HIS and RIS systems. Information is retrieved and displayed on LC
shrill
发表于 2025-3-27 20:07:00
http://reply.papertrans.cn/19/1813/181273/181273_36.png
debble
发表于 2025-3-27 23:03:26
Cyclotron and Production of PET Radionuclides,roton) are accelerated under a radiofrequency high voltage in a magnetic field. In medical cyclotrons, H. ions are externally extracted out of the cyclotron and intended targets are positioned in the path of the proton beam, whereby positron-emitting nuclides of interest such as .C, .F, .N etc., are
考博
发表于 2025-3-28 03:20:41
http://reply.papertrans.cn/19/1813/181273/181273_38.png
Paleontology
发表于 2025-3-28 08:47:06
FDA Regulations for PET Radiopharmaceuticals,als of an IND, NDA, RDRC, Exploratory IND, and Expanded Access IND are discussed along with the requirements by 21CFR212 and USP Chapter <823> for compounding of PET radiopharmaceuticals. The certification and training requirements for physicians and technologists in different imaging modalities are
傲慢人
发表于 2025-3-28 13:03:09
NRC Regulations for Radiation Protection in PET,ciples and methods of radiation protection, receiving, storing and disposal of radioactive material, occupational dose limits, personnel monitoring, and radiation safety officer. Different pertinent rules and regulations for using PET radiopharmaceuticals in humans are elucidated in 10CFR35. The Dep